Cell Therapy

Top Story

P-BCMA-101 receives orphan drug designation for multiple myeloma

May 15, 2019
Meeting News

Targeting mutations a 'complex' must in cell therapy for solid tumors

May 15, 2019
PHILADELPHIA — Effectively treating solid epithelial cancers will require targeting a patient’s somatic cancer mutations, leading to highly complex…
Meeting News

Outpatient CAR T-cell therapy possible if done earlier

May 13, 2019
PHILADELPHIA — Chimeric androgen receptor T-cell therapy has a reputation as a game-changing therapy with a hefty price tag. However, as CAR T-cell therapy pioneer…
Feature

Costs, lengths of stay after CAR T-cell therapy greater for younger patients

May 10, 2019
Two studies presented at this year’s Transplantation & Cellular Therapy Meetings provided new insights into treatment costs and hospital stays associated with…
More Headlines »
CME ABIM MOC

Ace the Case: A 62-Year-Old Man Presents With Increasing Fatigue, Weight Loss, and Night Sweats for the Past 8 Months

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 62-year-old man who presents to your…
More »
Video
Meeting News

VIDEO: Transparency improves patient care, builds just culture

April 17, 2019
More »
CME

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

The integration of immune checkpoint inhibitors into treatment algorithms for patients with bladder cancer who have…
More »